Aurora Cannabis (ACB)
(Delayed Data from NSDQ)
$7.20 USD
-0.22 (-2.96%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $7.27 +0.07 (0.97%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth F Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.20 USD
-0.22 (-2.96%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $7.27 +0.07 (0.97%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth F Momentum D VGM
Zacks News
Aurora Cannabis Inc. (ACB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $5.50, marking a +0.92% move from the previous day.
Implied Volatility Surging for Aurora Cannabis (ACB) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
Aurora Cannabis Inc. (ACB) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of 50.00% and -0.21%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Aurora Cannabis (ACB) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Continued strength in Aurora Cannabis' (ACB) domestic-adult-recreational segment is expected to have driven Q1 sales.
Aurora Cannabis Inc. (ACB) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aurora Cannabis Inc. (ACB) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of 0.00% and -2.78%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Aurora Cannabis Inc. (ACB) Q4 Earnings Expected to Decline
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Cannabis Giant Tilray (TLRY) Skyrocketed Today
by Madeleine Johnson
Shares of Tilray (TLRY) closed sharply higher in Wednesday's trading session, gaining 25.8% after reporting mixed fourth-quarter earnings results.
Aurora Cannabis Inc. (ACB) Stock Jumps 7.7%: Will It Continue to Soar?
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Do Options Traders Know Something About Aurora Cannabis (ACB) Stock We Don't?
by Aditi Saraogi
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
Company News for May 17, 2021
by Zacks Equity Research
Companies In The News Are: ACB, NEWR, BLFS, GLOB
Aurora Cannabis Inc. (ACB) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of -41.18% and -21.05%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Aurora Cannabis (ACB) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Aurora Cannabis' (ACB) sturdy consumer cannabis sales are likely to have benefited its performance in the fiscal third quarter.
Will Aurora Cannabis Inc. (ACB) Report Negative Earnings Next Week? What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $8.96, marking a -0.99% move from the previous day.
Marijuana Stocks To Consider Before Celebrating 420
by Daniel Laboe
In the wake of this marijuana holiday's inevitable festivities, the US house of representatives passed the SAFE Banking Act, which would give US marijuana companies access to funding from federally insured banks.
Do Options Traders Know Something About Aurora (ACB) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Aurora (ACB) stock based on the movements in the options market lately.
Aurora Cannabis Inc. (ACB) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of -47.37% and -4.99%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Aurora Cannabis (ACB) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Aurora Cannabis' (ACB) sustained consumer cannabis sales are likely to have benefited its performance in the fiscal second quarter.
Cannabis ETFs Spike on Jazz-GW Pharma Deal
by Sweta Killa
Jazz Pharmaceuticals (JAZZ) agreed to buy cannabinoid drug company GW Pharmaceuticals (GWPH) for $7.2 billion in cash and stock that has strengthened the bullish case for the cannabis industry.
Aurora Cannabis Inc. (ACB) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed at $11.20 in the latest trading session, marking a +0.45% move from the prior day.
Aurora Cannabis Inc. (ACB) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $12.04, marking a +0.67% move from the previous day.
Are Options Traders Betting on a Big Move in Aurora Cannabis (ACB) Stock?
by Zacks Equity Research
Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.
Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $10.19, marking a -0.78% move from the previous day.
Aurora Cannabis Inc. (ACB) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Aurora Cannabis Inc. (ACB) closed at $9.60 in the latest trading session, marking a -1.34% move from the prior day.